Compare AVTR & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVTR | PODD |
|---|---|---|
| Founded | 1904 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5B | 10.2B |
| IPO Year | 2019 | 2007 |
| Metric | AVTR | PODD |
|---|---|---|
| Price | $15.03 | $130.79 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 17 | 25 |
| Target Price | $14.66 | ★ $171.91 |
| AVG Volume (30 Days) | ★ 7.9M | 1.2M |
| Earning Date | 10-28-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.06 | ★ 2.67 |
| Revenue | ★ $6,552,200,000.00 | $2,708,100,000.00 |
| Revenue This Year | $0.63 | $21.38 |
| Revenue Next Year | $2.36 | $13.78 |
| P/E Ratio | $254.00 | ★ $49.26 |
| Revenue Growth | N/A | ★ 30.73 |
| 52 Week Low | $7.27 | $126.40 |
| 52 Week High | $16.05 | $354.88 |
| Indicator | AVTR | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 54.78 | 35.96 |
| Support Level | $13.20 | $131.24 |
| Resistance Level | $16.05 | $153.33 |
| Average True Range (ATR) | 0.44 | 3.84 |
| MACD | -0.10 | -0.44 |
| Stochastic Oscillator | 35.47 | 12.17 |
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.